Sign in
bf/NASDAQ:ABCL_icon.jpeg

NASDAQ:ABCL

AbCellera Biologics Inc.

  • Stock

USD

Last Close

3.10

26/07 20:00

Market Cap

823.35M

Beta: −0.12

Volume Today

692.61K

Avg: 1.63M

PE Ratio

−11.06

PFCF: −20.83

OverviewFinancialsFilingspeopleOwnershipAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.41
-
0.49
20.31%
0.23
53.10%
0.28
22.72%
0.32
10.71%
0.03
91.89%
cash conversion cycle
83.74
-
-87.13
204.05%
-144.69
66.06%
329.70
327.87%
cash per share
0.05
-
0.04
27.68%
3.73
10,543.94%
2.62
29.75%
3.11
18.62%
2.63
15.42%
company equity multiplier
1.85
-
2.29
23.75%
1.21
47.15%
1.29
6.17%
1.25
2.80%
1.29
3.36%
days of inventory outstanding
18.93
-
13.41
29.18%
8.42
37.23%
13.08
55.39%
days of payables outstanding
269.01
-
256.75
4.56%
182.13
29.06%
301.38
65.48%
days of sales outstanding
172.25
-
137.61
20.11%
333.82
142.58%
156.21
53.21%
29.02
81.42%
618.00
2,029.65%
dividend yield
ebit per revenue
-0.09
-
-0.35
315.82%
0.67
288.74%
0.54
18.59%
0.45
18.13%
-6.24
1,498.62%
ebt per ebit
-0.41
-
0.54
230.85%
1.01
88.38%
1.07
5.98%
1.10
3.01%
0.73
33.57%
effective tax rate
4.12
-
-0.09
102.29%
0.25
360.55%
0.30
21.56%
0.34
12.44%
0.16
52.89%
enterprise value multiple
7.04K
-
-37.24K
628.93%
34.24
100.09%
14.45
57.80%
9.35
35.28%
-8.30
188.77%
fixed asset turnover
1.40
-
1.37
1.85%
13.01
850.03%
3.36
74.16%
2.23
33.53%
0.13
94.08%
free cash flow per share
-0.01
-
-0.01
25.19%
0.05
932.45%
0.67
1,240.30%
0.72
6.39%
-0.42
158.46%
gross profit margin
1
-
1
0%
0.88
11.64%
0.88
0.55%
0.86
1.77%
0.19
78.27%
interest coverage
-3.55
-
-19.68
454.08%
23.96
221.77%
39.12
63.25%
53.53
36.82%
inventory turnover
19.28
-
27.22
41.21%
43.37
59.30%
27.91
35.65%
long term debt to capitalization
0.07
-
0.28
285.97%
0.01
97.48%
0.03
384.94%
0.06
70.74%
0.06
0.55%
net income per ebt
1
-
1.09
9.46%
0.75
31.17%
0.70
7.06%
0.66
5.32%
0.84
26.88%
net profit margin
0.03
-
-0.21
695.60%
0.51
344.74%
0.41
19.81%
0.33
20.16%
-3.85
1,278.98%
operating cash flow per share
0.02
-
0.01
24.44%
0.14
1,039.80%
0.89
522.28%
0.97
9.70%
-0.15
115.59%
operating cycle
352.76
-
169.62
51.92%
37.44
77.93%
631.08
1,585.77%
operating profit margin
-0.09
-
-0.35
315.82%
0.67
288.74%
0.54
18.59%
0.45
18.13%
-6.24
1,498.62%
payables turnover
1.36
-
1.42
4.78%
2.00
40.97%
1.21
39.57%
pretax profit margin
0.03
-
-0.19
644.11%
0.68
455.56%
0.58
13.72%
0.49
15.67%
-4.58
1,029.17%
price fair value
1.09K
-
1.24K
13.24%
7.71
99.38%
3.84
50.16%
2.34
39.10%
1.43
38.80%
receivables turnover
2.12
-
2.65
25.17%
1.09
58.78%
2.34
113.70%
12.58
438.30%
0.59
95.30%
return on assets
0.01
-
-0.10
816.59%
0.12
214.79%
0.12
1.59%
0.10
11.61%
-0.10
195.63%
return on capital employed
-0.05
-
-0.26
428.01%
0.17
165.51%
0.17
1.35%
0.15
10.81%
-0.17
213.84%
return on equity
0.03
-
-0.24
986.80%
0.14
160.66%
0.15
4.49%
0.13
14.09%
-0.13
198.84%
total debt to capitalization
0.23
-
0.40
75.75%
0.01
98.19%
0.04
415.31%
0.06
66.34%
0.06
0.64%

All numbers in USD (except ratios and percentages)